These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Implication of BRCA1 gene in breast cancer. Kachhap SK, Ghosh SN. Indian J Exp Biol; 2001 May; 39(5):391-400. PubMed ID: 11510120 [Abstract] [Full Text] [Related]
3. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB. Menendez JA, Mehmi I, Atlas E, Colomer R, Lupu R. Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544 [Abstract] [Full Text] [Related]
4. BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair. Hartman AR, Ford JM. Nat Genet; 2002 Sep; 32(1):180-4. PubMed ID: 12195423 [Abstract] [Full Text] [Related]
5. BRCA1 gene in breast cancer. Rosen EM, Fan S, Pestell RG, Goldberg ID. J Cell Physiol; 2003 Jul; 196(1):19-41. PubMed ID: 12767038 [Abstract] [Full Text] [Related]
6. Highlight: BRCA1 and BRCA2 proteins in breast cancer. Daniel DC. Microsc Res Tech; 2002 Oct 01; 59(1):68-83. PubMed ID: 12242698 [Abstract] [Full Text] [Related]
7. BRCA1 regulation of transcription. Rosen EM, Fan S, Ma Y. Cancer Lett; 2006 May 18; 236(2):175-85. PubMed ID: 15975711 [Abstract] [Full Text] [Related]
8. BRCA1 and BRCA2 are necessary for the transcription-coupled repair of the oxidative 8-oxoguanine lesion in human cells. Le Page F, Randrianarison V, Marot D, Cabannes J, Perricaudet M, Feunteun J, Sarasin A. Cancer Res; 2000 Oct 01; 60(19):5548-52. PubMed ID: 11034101 [Abstract] [Full Text] [Related]
9. Role of direct interaction in BRCA1 inhibition of estrogen receptor activity. Fan S, Ma YX, Wang C, Yuan RQ, Meng Q, Wang JA, Erdos M, Goldberg ID, Webb P, Kushner PJ, Pestell RG, Rosen EM. Oncogene; 2001 Jan 04; 20(1):77-87. PubMed ID: 11244506 [Abstract] [Full Text] [Related]
11. Breast cancer risk and the DNA double-strand break end-joining capacity of nonhomologous end-joining genes are affected by BRCA1. Bau DT, Fu YP, Chen ST, Cheng TC, Yu JC, Wu PE, Shen CY. Cancer Res; 2004 Jul 15; 64(14):5013-9. PubMed ID: 15256476 [Abstract] [Full Text] [Related]
12. The role of the BRCA1 tumor suppressor in DNA double-strand break repair. Zhang J, Powell SN. Mol Cancer Res; 2005 Oct 15; 3(10):531-9. PubMed ID: 16254187 [Abstract] [Full Text] [Related]
13. BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. Elstrodt F, Hollestelle A, Nagel JH, Gorin M, Wasielewski M, van den Ouweland A, Merajver SD, Ethier SP, Schutte M. Cancer Res; 2006 Jan 01; 66(1):41-5. PubMed ID: 16397213 [Abstract] [Full Text] [Related]
14. BRCA1-associated complexes: new targets to overcome breast cancer radiation resistance. Chen X, Arciero CA, Godwin AK. Expert Rev Anticancer Ther; 2006 Feb 01; 6(2):187-96. PubMed ID: 16445371 [Abstract] [Full Text] [Related]
15. Emerging roles of BRCA1 in transcriptional regulation and DNA repair. Chen Y, Lee WH, Chew HK. J Cell Physiol; 1999 Dec 01; 181(3):385-92. PubMed ID: 10528224 [Abstract] [Full Text] [Related]
16. Roles of BRCA1 and its interacting proteins. Deng CX, Brodie SG. Bioessays; 2000 Aug 01; 22(8):728-37. PubMed ID: 10918303 [Abstract] [Full Text] [Related]
17. BRCA1 in breast and ovarian cancer predisposition. Billack B, Monteiro AN. Cancer Lett; 2005 Sep 08; 227(1):1-7. PubMed ID: 16051027 [Abstract] [Full Text] [Related]
18. BCoR-L1 variation and breast cancer. Lose F, Arnold J, Young DB, Brown CJ, Mann GJ, Pupo GM, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Khanna KK, Chenevix-Trench G, Spurdle AB. Breast Cancer Res; 2007 Sep 08; 9(4):R54. PubMed ID: 17697391 [Abstract] [Full Text] [Related]
19. BRCA1 and FOXA1 proteins coregulate the expression of the cell cycle-dependent kinase inhibitor p27(Kip1). Williamson EA, Wolf I, O'Kelly J, Bose S, Tanosaki S, Koeffler HP. Oncogene; 2006 Mar 02; 25(9):1391-9. PubMed ID: 16331276 [Abstract] [Full Text] [Related]
20. AKT and p21 WAF1/CIP1 as potential genistein targets in BRCA1-mutant human breast cancer cell lines. Privat M, Aubel C, Arnould S, Communal Y, Ferrara M, Bignon YJ. Anticancer Res; 2010 Jun 02; 30(6):2049-54. PubMed ID: 20651350 [Abstract] [Full Text] [Related] Page: [Next] [New Search]